Sensors · 2017 · 21 citations · 13 references
EngineeringBioengineeringBiotechnologyMedical RoboticsNanobiotechnologyNanotechnologyAngiogenesisCancer BiotechnologyCancer NanomedicineMicrofluidic DevicesMicrofluidicsNanomedicineAngiogenic Factor ExpressionCellular ChemotaxisChemotaxisEscherichia ColiMicrofluidic Device DesignMicrofluidic SensingNano SensorsVascular Endothelial Growth Factor
This paper reports a novel self-detection method for tumor cells using living nano-robots. These living robots are a nonpathogenic strain of E. coli bacteria equipped with naturally synthesized bio-nano-sensory systems that have an affinity to VEGF, an angiogenic factor overly-expressed by cancer cells. The VEGF-affinity/chemotaxis was assessed using several assays including the capillary chemotaxis assay, chemotaxis assay on soft agar, and chemotaxis assay on solid agar. In addition, a microfluidic device was developed to possibly discover tumor cells through the overexpressed vascular endothelial growth factor (VEGF). Various experiments to study the sensing characteristic of the nano-robots presented a strong response toward the VEGF. Thus, a new paradigm of selective targeting therapies for cancer can be advanced using swimming E. coli as self-navigator miniaturized robots as well as drug-delivery vehicles.
13
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Napoleone Ferrara, Karen Carver-Moore, Helen Chen et al. · Nature · 1996 · 3.7K citations · Full text